Skip to main content
SpringerLink
Log in

Long-term nitrofurantoin: risk of pulmonary fibrosis

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see Reactions 1415 p4; 803075098

Reference

  • Danish Health and Medicines Authority. Be aware of the risk of pulmonary fibrosis in long-term treatment with nitrofurantoin (Nitrofurantoin DAK) - new review and analysis by DHMA. Danish Pharmacovigilance Update 6: 4, No. 2, Feb 2015. Available from: URL: sundhedsstyrelsen.dk/en

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Long-term nitrofurantoin: risk of pulmonary fibrosis. Reactions Weekly 1545, 5 (2015). https://doi.org/10.1007/s40278-015-9096-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-9096-0

Search

Navigation